NanoAssemblr™ Benchtop, NanoAssemblr Spark
Cat#:Benchtop,Spark
Price:Please call：86-10-67529703
Brand:nanoassemblr
  • SystemsTransfection KitsFormulation Solutions
    OVERVIEWSparkBenchtopBlazeScale-up
    The NanoAssemblr Platform encompasses Precision NanoSystems’ suite of products that provide seamless manufacturing of nanoparticles from 25 μL to 25 L to support early stage discovery through production of clinical material.

    Powering nanoparticle research, development and manufacture

    BROCHURE

    The NanoAssemblr Platform encompasses Precision NanoSystems’ suite of products that provide seamless manufacturing of nanoparticles (liposomes, lipid nanoparticles, polymeric nanoparticles) from 25 μL to 25 L to support early stage discovery through production of clinical material. At its core lies microfluidic mixing technology that mediates bottom-up self-assembly for nanoparticle synthesis with reproducible results and low polydispersity. Tweaking parameters such as mixing ratios, flow rate and particle composition enables tuning for size, nanoparticle encapsulation efficiency and much more.

    • NanoAssemblr Spark: Drug screening & disease target identification via cell transfection. Manufactures 25 uL – 250 uL per run.
    • NanoAssemblr Benchtop: Rapid nanomedicine candidate development. Manufactures 1 mL – 15 mL per run.
    • NanoAssemblr Blaze: Larger pre-clinical testing of nanomedicines and early Chemistry, Manufacturing, and Controls investigation. Manufactures 10 mL – 1000 mL per run.
    The NanoAssemblr Spark has an operating nanoparticle formulation volume of 25 – 250 μL. By ensuring yields nearing 100%, the Spark is ideal for target validation screening and nanoparticle formulation development that involves scarce or expensive nucleic acid constructs and nanoparticle excipients.

    The NanoAssemblr Spark has an operating nanoparticle formulation volume of 25 – 250 μL. By ensuring yields nearing 100%, the Spark is ideal for target validation screening and nanoparticle formulation development that involves scarce or expensive nucleic acid constructs and nanoparticle excipients.
    REQUEST QUOTE

    The NanoAssemblr Benchtop is a formulation system that gives researchers reproducibility and ease-of-use for iterating on nanoparticle design and therapeutic delivery experiments.

    The NanoAssemblr Benchtop system is designed for rapid prototyping of novel nanoparticle formulations of 1 to 15mL, that would be difficult to make with alternative manufacturing methods. Software enables the control of input mixing parameters for optimizing particle characteristics such as size and encapsulation efficiency.
    REQUEST QUOTE

    The NanoAssemblr Blaze is enabling for researchers and drug development programs. The dynamic volume range allows researchers to use the Blaze for nanoparticle discovery, preclinical toxicology testing and for early Chemistry, Manufacturing and Controls (CMC) studies.

    The NanoAssemblr Blaze bridges the gap between nanoparticle discovery and clinical development. The system can manufacture between 10 mL and 1 L which allows researchers to use the Blaze for nanoparticle discovery, for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) studies.